Renhua Guo
300 Guangzhou Road
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer.
Journal: NPJ precision oncology
Published: November 27, 2024
Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy.
Journal: Journal of translational medicine
Published: September 09, 2024
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 26, 2024
A clinical decision support system to predict the efficacy for EGFR-TKIs based on artificial neural network.
Journal: Journal of cancer research and clinical oncology
Published: May 18, 2023
B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 17, 2023
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Journal: Journal for immunotherapy of cancer
Published: October 21, 2022
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.
Journal: Cell death & disease
Published: October 04, 2022
Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC.
Journal: Journal of cancer research and clinical oncology
Published: December 10, 2021
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.
Journal: Molecular cancer
Published: November 28, 2021
Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.
Journal: Oncogene
Published: September 24, 2021
A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.
Journal: Molecular genetics and genomics : MGG
Published: August 18, 2021
Last Updated: 09/26/2026